Elizabeth Gerard, MD: Considering Genetic Testing for Adult Epileptics
February 19th 2020The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine discussed the reasons an adult with epilepsy may seek genetic testing and what benefits it can provide.
White Matter Hyperintensities May Increase Risk of Levodopa-Induced Dyskinesia in Parkinson Disease
February 19th 2020Patients with Parkinson disease with moderate to severe white matter hyperintensity (WMH) burden had a greater risk of developing levodopa-induced dyskinesia compared with those with minimal WMHs.
Amantadine Successful in Reducing Dyskinesia: Clinical Takeaways
February 17th 2020The vice president of Medical Affairs at Adamas Pharmaceuticals discussed the context of these results and what the clinical community should take away from the data from the EASE LID 2 trial of amantadine (Gocovri).
Elizabeth Gerard, MD: Advances in Genetic Testing for Epilepsy
February 16th 2020The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine spoke about the evolving landscape of the use of genetic tools in epilepsy.
Outpatient Palliative Care Model Shows Potential for Parkinson Disease and Related Disorders
February 15th 2020This novel trial’s positive outcome suggests that a multidisciplinary outpatient model is possible to integrate into care beyond just those who are most vulnerable in institutional care.